[1]
Haro I, Sanmartí R, Gómara MJ. Implications of post-translational modifications in autoimmunity with emphasis on citrullination, homocitrullination and acetylation for the pathogenesis, diagnosis and prognosis of rheumatoid arthritis. International Journal of Molecular Sciences 23(24): 2022.
[2]
MJ. Gomara, R. Pons, C. Herrera, P. Ziprin IH. Peptide amphiphilic-based supramolecular structures with Anti-HIV-1 activity. Bioconjugate Chemistry 32(9): 1999-2013, 2021.
[3]
García-Moreno C, Gómara MJ, Castellanos-Moreira R, Sanmartí R, Haro I. Peptides bearing multiple post-translational modifications as antigenic targets for severe rheumatoid arthritis patients. International Journal of Molecular Sciences 22(24): 2021.
[4]
Gomara MJ, Perez Y, Gomez-Gutierrez P, et al. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide. Scientific Reports 10: 14430, 2020.
[5]
Castellanos-Moreira R, Rodríguez-García S, Gomara MJ, et al. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Annals of the Rheumatic Diseases 79: 587-594, 2020.
[6]
Davide Schiroli, María J. Gómara, Eleonora Maurizi, et al. Effective in vivo topical delivery of siRNA and gene silencing in intact corneal epithelium using a modified cell penetrating peptide. Molecular Therapy Nucleic Acids 17: 891-906, 2019.
[7]
Cristina García-Moreno, María José Gómara, María José Bleda, Raimon Sanmartí, Isabel Haro. A multiplex assay based on chimeric citrullinated peptides for the diagnosis of rheumatoid arthritis. PLOS One 14(5): e0215927, 2019.
[8]
Yolanda Pérez, María J. Gómara, Eloísa Yuste, Patricia Gómez-Gutiérrez, Juan J. Pérez, Isabel Haro. Structural study of a new HIV-1 entry inhibitor and interaction with the HIV-1 fusion peptide in dodecylphosphocholine micelles. Chemistry: A European Journal 23: 11703-11713, 2017.
